Literature DB >> 8908515

An expanded CAG repeat sequence in spinocerebellar ataxia type 7.

K Lindblad1, M L Savontaus, G Stevanin, M Holmberg, K Digre, C Zander, H Ehrsson, G David, A Benomar, E Nikoskelainen, Y Trottier, G Holmgren, L J Ptacek, A Anttinen, A Brice, M Schalling.   

Abstract

Expanded CAG repeat sequences have been identified in the coding region of genes mutated in several neurodegenerative disorders, including spinocerebellar ataxia type 1 and Machado-Joseph disease. In all disorders described to date the CAG expansion codes for an elongated polyglutamine chain. An increased polyglutamine chain size leads to a more severe disease, thus correlating with the genetic anticipation seen in repeat expansion disorders. Spinocerebellar ataxia type 7 (SCA7) is an autosomal dominant spinocerebellar ataxia with anticipation and a progressive degeneration of the cerebellar cortex. Using repeat expansion detection (RED), a method in which a thermostable ligase is used to detect repeat expansions directly from genomic DNA, we have analyzed 8 SCA7 families for the presence of CAG repeat expansions. RED products of 150-240 bp were found in all affected individuals and found to cosegregate with the disease (P < 0.000001, n = 66), indicating strongly that a CAG expansion is the cause of SCA7. On the basis of a previously established correlation between RED product sizes and actual repeat sizes in Machado-Joseph disease, we were able to estimate the average expansion size in SCA7 to be 64 CAG copies.

Entities:  

Mesh:

Year:  1996        PMID: 8908515     DOI: 10.1101/gr.6.10.965

Source DB:  PubMed          Journal:  Genome Res        ISSN: 1088-9051            Impact factor:   9.043


  26 in total

Review 1.  The complex clinical and genetic classification of inherited ataxias. I. Dominant ataxias.

Authors:  S Di Donato
Journal:  Ital J Neurol Sci       Date:  1998-12

2.  Posttranslational modification of ataxin-7 at lysine 257 prevents autophagy-mediated turnover of an N-terminal caspase-7 cleavage fragment.

Authors:  Shona Mookerjee; Theodora Papanikolaou; Stephan J Guyenet; Vanitha Sampath; Amy Lin; Cathy Vitelli; Francesco DeGiacomo; Bryce L Sopher; Sylvia F Chen; Albert R La Spada; Lisa M Ellerby
Journal:  J Neurosci       Date:  2009-12-02       Impact factor: 6.167

Review 3.  The genetic defect causing Huntington's disease: repeated in other contexts?

Authors:  J F Gusella; F Persichetti; M E MacDonald
Journal:  Mol Med       Date:  1997-04       Impact factor: 6.354

Review 4.  The role for alterations in neuronal activity in the pathogenesis of polyglutamine repeat disorders.

Authors:  Ravi Chopra; Vikram G Shakkottai
Journal:  Neurotherapeutics       Date:  2014-10       Impact factor: 7.620

Review 5.  Histone acetylation, acetyltransferases, and ataxia--alteration of histone acetylation and chromatin dynamics is implicated in the pathogenesis of polyglutamine-expansion disorders.

Authors:  Shaun D McCullough; Patrick A Grant
Journal:  Adv Protein Chem Struct Biol       Date:  2010       Impact factor: 3.507

Review 6.  The discovery of human of GLUD2 glutamate dehydrogenase and its implications for cell function in health and disease.

Authors:  Pullanipally Shashidharan; Andreas Plaitakis
Journal:  Neurochem Res       Date:  2013-12-19       Impact factor: 3.996

7.  Histone deacetylase inhibitors reduce polyglutamine toxicity.

Authors:  A McCampbell; A A Taye; L Whitty; E Penney; J S Steffan; K H Fischbeck
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-11       Impact factor: 11.205

8.  Structural insights into the assembly and function of the SAGA deubiquitinating module.

Authors:  Nadine L Samara; Ajit B Datta; Christopher E Berndsen; Xiangbin Zhang; Tingting Yao; Robert E Cohen; Cynthia Wolberger
Journal:  Science       Date:  2010-04-15       Impact factor: 47.728

9.  Multivariate analysis of factors influencing repeat expansion detection.

Authors:  C Zander; J Thelaus; K Lindblad; M Karlsson; K Sjöberg; M Schalling
Journal:  Genome Res       Date:  1998-10       Impact factor: 9.043

10.  Inhibition of α-ketoglutarate-and pyruvate dehydrogenase complexes in E. coli by a glutathione S-transferase containing a pathological length poly-Q domain: A possible role of energy deficit in neurological diseases associated with poly-Q expansions?

Authors:  A J Cooper; K F Sheu; J R Burke; O Onodera; W J Strittmatter; A D Roses; J P Blass
Journal:  Age (Omaha)       Date:  1998-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.